Evidence map›Paper›PMID 42597364›Full record

ReviewFrontiers in radiology2026

Portal vein recanalization and transjugular intrahepatic portosystemic shunt in chronic portal vein thrombosis: a narrative review.

Valentina Mejía-Quiñones, José Gabriel Lotero-Robledo, José Miguel Hidalgo-Oviedo, Juan S Toro-Gutiérrez, Jorge Mario Sastoque-Gómez

Abstract readReview
In one paragraph

Review in Frontiers in radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Valentina Mejía-QuiñonesCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
José Gabriel Lotero-RobledoRadiólogo Intervencionista y de Imagen Corporal, Clínica CES, Medellín, Colombia.
José Miguel Hidalgo-OviedoRadiólogo Intervencionista, Hospital Pablo Tobón Uribe, Medellín, Colombia.
Juan S Toro-GutiérrezRadiólogo Intervencionista, Departamento de Intervencionismo Vascular, Fundación Valle del Lili, Cali, Colombia.
Jorge Mario Sastoque-GómezRadiólogo Intervencionista, Clínica CES, Medellín, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Portal vein thrombosis (PVT) is a heterogeneous and clinically significant complication of liver cirrhosis, primary hepatobiliary malignancy, and various systemic prothrombotic states. It is associated with advanced portal hypertension, increased surgical complexity during liver transplantation, and higher mortality. The aim of this manuscript is to provide a narrative review of PVT and portal vein recanalization combined with transjugular intrahepatic portosystemic shunt (PVR-TIPS), detailing epidemiology, pathophysiology, and diagnostic classifications while exploring evolving medical and interventional management strategies. A comprehensive narrative review of the existing literature was conducted, incorporating clinical practice guidelines from major societies (AASLD, Baveno VII, EASL, and AGA) and recent prospective and retrospective studies regarding the management of non-malignant PVT in both cirrhotic and non-cirrhotic patients. PVT occurs in approximately 1% of the general population but affects up to 44% of candidates for liver transplantation (LT). Its development is governed by Virchow's triad, with reduced portal flow velocity (<15 cm/s) being the primary independent predictor in cirrhosis. Diagnosis relies on Doppler ultrasound as a first-line screening tool, followed by contrast-enhanced computed tomography or magnetic resonance imaging to define the degree of occlusion, extent, and chronicity using standardized nomenclature. Medical management with anticoagulation is the cornerstone for recent PVT (<6 months), achieving recanalization in 40%-75% of cases. For chronic obliterative PVT or refractory complications (variceal bleeding or refractory ascites), PVR-TIPS has emerged as a safe and highly successful intervention, with technical success rates ranging from 75% to 100% in expert centers. PVR-TIPS facilitates physiologic end-to-end portal anastomosis during LT in up to 96%-100% of cases, significantly improving transplant feasibility and outcomes. The management of PVT has transitioned toward highly individualized strategies. Standardized classification remains essential for guiding therapy. While medical management is effective for recent-onset disease, PVR-TIPS represents a transformative interventional advancement for chronic obliterative PVT, restoring physiologic flow and optimizing candidates for curative liver transplantation.

Indexed as

anticoagulationcirrhosisliver transplantationportal vein recanalizationportal vein thrombosistransjugular intrahepatic portosystemic shunt

Identifiers

PMID42597364
PMCPMC13469255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.